(Reuters) – Roche said the head of its diagnostics division, Thomas Schinecker, is to become group chief executive next year, replacing Severin Schwan, who will take the role of chairman of the board of directors.
Chairman Christoph Franz will not seek re-election after nine years as board chairman at the next annual shareholder meeting in March 2023, the Swiss drugmaker said in a statement on Thursday.
(Reporting by Ludwig Burger, editing by Kirsti Knolle)
